Education / Certification
M.D., State University of New York Health Science Center at Brooklyn, College of Medicine – 1993
M.S., University of Rochester School of Medicine and Dentistry – 1991
B.S., Department of Pharmacology, City University of New York – 1988
Research and Professional Experience
Primary Care Residency Program in Internal Medicine, University of Rochester School of Medicine and Dentistry – 1993-1995
Fellow, Cardiology and Electrophysiology, University of Rochester School of Medicine and Dentistry – 1995-2000
Senior Instructor of Medicine, University of Rochester School of Medicine and Dentistry – 2000-2001
Assistant Professor of Medicine, University of Rochester School of Medicine and Dentistry – 2001-05/2008
Associate Professor of Medicine, University of Rochester School of Medicine and Dentistry – 06/2008-Present
Spencer Rosero is an Associate Professor of Medicine/Cardiology and Director of the Pacemaker Clinic. He also serves as Co-Director of the Hereditary Arrhythmia Clinic of the University of Rochester which is involved in the care of families with hereditary heart rhythm disorders such as Long QT Syndrome, Brugada’s Syndrome, ARVD, and Idiopathic Ventricular Fibrillation. He joined the University of Rochester faculty in 2000 and is certified by the American Board of Internal Medicine in Internal Medicine, Cardiovascular Disease, and Clinical Cardiac Electrophysiology and Pacing.
He specializes in the management of heart rhythm disorders including: Inpatient and outpatient consultations on patients with bradyarrhythmias and tachyarrhythmias, permanent pacemaker implantation, defibrillator (ICD) implantation for the prevention of sudden cardiac death, cardiac resynchronization therapy for congestive heart failure, diagnostic electrophysiologic testing, radiofrequency catheter ablation of abnormal heart rhythms.
With his colleagues, Drs. Huang, Daubert and Hall, Dr. Rosero is an investigator in several clinical research projects. The University of Rochester participated in large multi-center implantable device trials such as Executive Committee of the recently completed Multicenter Automatic Defibrillator Implantation Trial II (MADIT II), COMPANION Trial, and the MIRACLE resynchronization therapy trial. New mapping and ablation catheter investigations as well as antiarrhythmic medication investigations are conducted.
A new NIH-sponsored grant examining noninvasive and invasive diagnosis of Long QT Syndrome has recently been started.
Publications
- An RH, Bangalore R, Rosero SZ, Kass RS. Lidocaine block of LQT-3 mutant human Na+ channels. Circulation Research, 1996; 79(1):103-8.
- Zareba W, Moss AJ, Rosero SZ, Hajj-Ali R, Konecki J, Andrews M. American Journal of Cardiology 1997;80(9):1168-73.
- Rosero SZ, Zareba W, Moss AJ, Robinson RJ, Hajj Ali RH, Locati EH, Benhorin J. Andrews ML. Asthma and the risk of cardiac events in the Long QT Syndrome. Long QT Syndrome Investigative Group. American Journal of Cardiology. 1999;84(12):1406-11.
Contact:
Dr. Spencer Rosero
Paul N. Yu Heart Center
Strong Memorial Hospital
601 Elmwood Ave
Ambulatory Center – Ground Floor
Rochester, NY 14642
Phone: 585-275-2475